Clinical Trials Browser

Withdrawn × Multiple Myeloma × Adjuvants, Immunologic × Clear all

NCT05950113 2024-05-01

CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Withdrawn

Multiple Myeloma